Schedule 13D ownership disclosure
ROYALTY PHARMA PLC- CL A
Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G7709Q104
Event date: 2025-11-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- R & H Trust Co. (Guernsey) Limited
Shares: 24,223,082 · Class: 5.7%
- Severgnini Achille G.Reported CIK 0001814880
Shares: 24,223,082 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-26-006327
- Form type
- SCHEDULE 13D/A
- Filer
- Royalty Pharma plc
- CIK
- CIK 1802768
- Filed
- Feb 20, 2026
- Reporting period
- Nov 06, 2025
- Description
- Schedule 13D beneficial ownership